University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
The James Cancer Hospital and Solove Research Institute, Columbus

ReclutandoFase 1/2

Edades de 16 a 75 · Todos los sexos · Actualizado el 10 sept 2026 · NCT03104491

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Summa Health System - Akron Campus, Akron
Cleveland Clinic Akron General, Akron
Summa Health System - Barberton Campus, Barberton
y 44 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT05334069

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Cincinnati Children's Hospital Medical Center, Cincinnati

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies and Childrens Hospital, Cleveland
y 3 más

ReclutandoFase 1/2

Hasta los 22 · Todos los sexos · Actualizado el 25 ago 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Cincinnati Children's Hospital Medical Center, Cincinnati

ReclutandoFase 2

Edades de 7 a 25 · Todos los sexos · Actualizado el 19 ago 2026 · NCT05082519

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Children's Hospital Medical Center, Cincinnati

ReclutandoEstudio observacional

1 Day – 17 Years · Todos los sexos · Actualizado el 14 ago 2026 · NCT06274788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Childrens Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital, Cincinnati
University Hospitals Case Medical Center, Cleveland
y 3 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Cincinnati Children's Hospital Medical Center, Cincinnati

ReclutandoFase 1/2

Hasta los 21 · Todos los sexos · Actualizado el 3 jun 2026 · NCT04195347

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Nationwide Children's Hospital, Columbus
Ohio State University Comprehensive Cancer Center, Columbus

ReclutandoFase 1

Edades de 2 en adelante · Todos los sexos · Actualizado el 29 may 2026 · NCT05418088

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 18 may 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Cincinnati Children's Hospital Medical Center, Cincinnati
University of Cincinnati, Cincinnati
The Ohio State University, Columbus

ReclutandoFase 1

Edades de 13 en adelante · Todos los sexos · Actualizado el 5 may 2026 · NCT04771572

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Ohio State University Medical Center, Columbus

ReclutandoFase 1

Edades de 18 a 65 · Todos los sexos · Actualizado el 25 mar 2026 · NCT03533816

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

The Ohio State University Comprehensive Cancer Center, Columbus

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 24 mar 2026 · NCT04988555

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Cleveland Clinic Foundation, Cleveland

ReclutandoFase 2

Edades de 18 a 54 · Todos los sexos · Actualizado el 17 mar 2026 · NCT06918431

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Cleveland Clinic, Cleveland

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2025 · NCT04260022

HPC Offered for PRESERVE Expansion

The Ohio State University Medical Center, Columbus

ReclutandoEstudio observacional

Edades de 12 a 80 · Todos los sexos · Actualizado el 28 ago 2025 · NCT07145411

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies, Cleveland
Nationwide Children's Hospital, Columbus

ReclutandoFase 1

Edades de 1 a 21 · Todos los sexos · Actualizado el 6 dic 2024 · NCT05476770

De ClinicalTrials.gov, datos obtenidos el 2 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.